For more than 50 years The Hospital Research Foundation (THRF) has played a vital role in the support of translational health and medical research that benefits the local community as well as communities across Australia and on a global scale.

The Foundation is proud to support leadership and innovation in research that translates into the provision of outstanding medical and nursing care in our hospitals and improved health and wellbeing in the community.

The Foundation provides Grants for research projects, programs and research personnel across a number of leading research facilities within South Australia‘s Central Adelaide Local Health Network (CALHN) and the Northern Adelaide Local Health Network (NALHN). These research partners and facilities include the Royal Adelaide Hospital (RAH), the Centre for Cancer Biology (CCB), The Queen Elizabeth Hospital (TQEH) and its research arm the Basil Hetzel Institute for Translational Health Research (BHI) as well as the Lyell McEwin Hospital (LMH).

Thanks to our donor community, 100% of donated funds are directed to the support of medical and health research at these prominent research facilities.

The Basil Hetzel Institute for Translational Health Research

The Basil Hetzel Institute for Translational Health Research (BHI) is the productive research arm of The Queen Elizabeth Hospital and home to almost 200 researchers and research administrative staff.

The BHI provides a dynamic, state-of-the-art research environment for vital ‘bench to bedside’ research and research training opportunities. Affiliated with the Universities of Adelaide, Flinders and the University of South Australia, the BHI is a short walk from The Queen Elizabeth Hospital, allowing for a vital and active interface between researchers and clinicians.

Opened in 2009, the facility was proudly named after the first Professor of Medicine at the hospital and one of Australia’s leading medical researchers, the Honorable Basil Hetzel AC. Revered world-wide for his pioneering work which discovered the link between iodized salt in the diet and the prevention of brain damage in newborns, Dr Hetzel’s groundbreaking research has helped millions of children in 130 countries where iodine is lacking.

His passion and drive to prevent brain damaged babies born as a result of iodine deficiency around the world has been recognized as one of the most significant medical discoveries of modern times.

Dr Hetzel has received numerous academic and humanitarian awards, not only for his landmark medical research but for his commitment, vision and leadership in the areas of public and community health.

His strong support for the translational medical research undertaken at the facility which proudly bears his name continues to inspire current researchers and those yet to make their mark in the field.

The Basil Hetzel Institute for Translational Health Research is home to almost 200 researchers and administrative staff.
The Basil Hetzel Institute for Translational Health Research in Woodville, SA is home to almost 200 researchers and administrative staff.

support lifesaving research by making a donation

Centre for Cancer Biology

The Centre for Cancer Biology (CCB) is a Medical Research Institute which carries out a world-class program of innovative research, making breakthrough discoveries in the causes of cancer, and translating these discoveries into new ways to prevent and treat this group of diseases.

The CCB is an alliance between SA Pathology and the University of South Australia and boasts over 200 cancer researchers; currently hosting 22 full-time research group leaders and their teams.

CCB laboratories carry out research on the major cancers such as leukaemia, bowel cancer, breast cancer, prostate cancer, lung cancer, ovarian cancer and skin cancers led by distinguished full-time group leaders. A particular focus is childhood cancers and cancers that occur in the same family. In addition to these laboratories, the CCB’s ACRF Cancer Genomics Facility provides access to state-of-the-art genomics to bring precision medicine to South Australian cancer patients.

The translation of new discoveries into clinical practice is strengthened by the location of the laboratories within a single centre, as well as its proximity to the Royal Adelaide Hospital along with its clinical resources, the University of South Australia and the University of Adelaide, with which it shares key research facilities.

The CCB has alliances with other prominent national and international Institutes and leading pharmaceutical companies which have allowed many of the discoveries made in this Institute, by South Australians, to be in advanced clinical trials worldwide. In this way the CCB is becoming a hub of internationally recognised cancer research excellence, achieving tangible outcomes for cancer patients.

The CCB is a member of the Association of Australian Medical Research Institutes (AAMRI).

The new home of the CCB, opening March 2018.
The new home of the CCB, opening March 2018.

donate to the centre for cancer biology